AGP Picks
View all

STEM Times Arkansas: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on STEM Times Arkansas.

Press releases published on November 19, 2026

Clearmind Medicine Expands PTSD Patent Portfolio with Hong Kong Patent Application Publication
SAIC Appoints Jeffrey Little to Lead its Army and Navy Business
Captiva Verde Brings Its Clean Water Mission for Communities and the Military to a National Audience with Red Apple Media
Polara Ranks No.139 on the 2026 Deloitte  Technology Fast 500™
Polara se classe au 139e rang du palmarès Deloitte Technology Fast 500™
Medicus Pharma Regains Compliance with Nasdaq Minimum Equity Requirement for Continued Listing
Palvella Therapeutics Announces QTORIN™ Docetaxel, a New QTORIN™ Program for the Treatment of Extramammary Paget’s Disease (EMPD)
Microchip Expands RT PolarFire® FPGA Portfolio with New Spaceflight Qualifications
Evaxion announces strategy and business update and third quarter 2026 financial results
Adagene Announces First Patient Dosed in Phase 1 Study of ADG138, a Novel HER2xCD3 Double-Masked Bispecific T-Cell Engager
Global research from Schneider Electric finds demand for on-prem AI infrastructure is surging due to sovereignty and compliance concerns
Korro to Participate in Upcoming Investor Conferences
aTyr Pharma Presents Preclinical Data for NRP2-Targeting Antibody ATYR2810 at the Connective Tissue Oncology Society (CTOS) 2026 Annual Meeting
Remix Therapeutics Announces Updated Positive REM-422 Phase 1 Data in Adenoid Cystic Carcinoma at 2026 EORTC-NCI-AACR Symposium
Regeneron Highlights New Data Across Malignant and Classical Hematology Programs at American Society of Hematology (ASH)
Climb adds Archer to its Security Portfolio, Bringing AI-Powered Risk, Compliance and Regulatory Change Management to VARs and MSPs
Verano Celebrates Grand Opening of MÜV Tarpon Springs, the Company’s 89th Florida Location, 166th Nationwide
Opus Genetics Announces First Participant Dosed in Phase 1/2 Clinical Trial of OPGx-RDH12 Gene Therapy for Rare Inherited Childhood Blindness
Marker Therapeutics Awarded $16.2 Million CPRIT Grant to Advance MT-601 in Phase 2 APOLLO Study
eCommerce Website Development: 62% of Shoppers Would Not Buy Without Their Preferred Payment Method

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

STEM Times Arkansas

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.